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ABSTRACT
ANALYSIS OF SEASONAL INFLUENZA VIROLOGIC AND HOSPITALIZATION
TRENDS AMONG CHILDREN IN THE UNITED STATES FROM 2010-2019
By
Samantha Rose Mandel
July 31, 2020
Background:

Each year, millions of children get sick with seasonal flu, thousands of children are hospitalized,
and some children die from flu. While the U.S. has a comprehensive influenza surveillance
system reporting on current flu activity, and the Centers for Disease Control and Prevention
(CDC) publishes weekly updates on their website (FluView), there is a lack of literature
analyzing trends among the virus types causing flu and flu-related hospitalizations among
children over multiple flu seasons. This study aimed to identify tends over time (2010-2019) in
the proportion of children with lab-confirmed flu and hospitalized for flu, along with the
proportion of virus types children are infected with.
Methods:

A secondary data analysis was conducted using the existing U.S. national influenza surveillance
data assembled and provided by the CDC. The study included children in the United States with
lab-confirmed flu or with flu-associated hospitalization during the 2010-2011 flu season through
the 2018-2019 flu season. Data from hospitalization surveillance and virologic surveillance were
analyzed across all 9 flu seasons.
Results:

Trends in the proportion of seasonal flu and flu-related hospitalizations among children showed a
significant decrease over time (2010-2019). Additionally, trends in the proportion of flu
A(H3N2) virus among children showed a significant decrease over time. While this study
revealed a strong, positive relationship between the proportion of flu and flu-related
hospitalizations among young children (0-4 yr) and older children (5-24 yr), a strong, negative
relationship was observed between the proportion of flu and flu-related hospitalizations among
children (0-4 yr) and older adults (65+).
Conclusion:

A significant decrease in proportion of flu and flu hospitalizations among children was observed
over time, revealing a trend of decreased burden of flu among children compared to other age
groups. A significant relationship was observed between children and older adults, revealing that
as trends of flu among children decreased, trends increased among older adults. Trends in
seasonal flu and flu-related complications have important implications for flu prevention and
control efforts.
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Introduction
Influenza (flu) is a contagious respiratory illness caused by influenza viruses. Flu can be
a serious disease that can lead to severe illness with complications, hospitalization and
sometimes even death 1. While flu can make anyone sick, certain groups of people are a high risk
of developing serious flu complications requiring hospitalization, including young children.
Each year, millions of children get sick with seasonal flu, thousands of children are
hospitalized, and some children die from the flu. CDC estimates that since 2010, flu-related
hospitalizations among children younger than 5 years ranges from 7,000 to 26,000 in the United
States 2. Since the 2004-2005 flu season, flu-related deaths in children reported to CDC during
regular flu seasons ranged from 37 deaths (during the 2011-2012 season) to 188 deaths (during
the 2017-2018 season) 2.
Flu vaccination can prevent illness, hospitalization and death in children. A study
published in 2017 was one of the first to show that flu vaccination can significantly reduce a
child’s risk of dying from the flu, highlighting the importance of children receiving a seasonal flu
vaccine each year 3. Unfortunately, flu continues to cause a heavy burden among this vulnerable
population 4. This is partially due to the variability in how well the flu vaccine works to protect
against flu illness from year to year.
Flu vaccines are made to protect against either three or four different influenza viruses
research shows are most likely to spread and cause illness among people during the upcoming flu
season. Since flu viruses are constantly changing, flu vaccines may be updated from one season
to the next based on which flu viruses are making people sick, how the viruses are spreading, and
how well the previous season’s flu vaccines protected against the circulating flu viruses.
The purpose of this study was to identify the trends of seasonal flu viruses that most
commonly circulate among children in the United States hospitalized for influenza since the
2010-2011 influenza season. Understanding these trends is useful for guiding prevention and
control efforts surrounding flu-burdened children. National and regional data was assessed from
the U.S. influenza surveillance systems. Lab-confirmed hospitalization data was analyzed to
identify trends in hospitalization rates among children over a nine consecutive flu seasons.
Circulating virus subtypes and lineages from U.S. virologic surveillance were compared with
hospitalization rates among children to analyze patterns in seasonal flu viruses and flu-related
hospitalizations among children.
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Literature Review
Overview of Influenza:
Influenza (or “flu”) is a contagious respiratory illness caused by influenza viruses that
can cause mild to severe illness, and at times can lead to hospitalization or even death. When a
person infected with flu coughs, sneezes or talks, droplets containing flu viruses can spread up to
six feet. These droplets can land in mouths and noses or possibly breathed into the lungs of
others. Influenza can also spread from touching a surface or object that has a flu virus on it 5.
Someone who is contagious with flu illness may be able to infect others asymptomatically and
up to 5-7 days after becoming sick. Children and some people with compromised immune
systems may be able to spread the flu virus for longer than seven days 5.
Influenza can be unpredictable. The timing and duration of flu seasons can vary each
year, but typically activity beings to increase in October, peaks between December and February
and can last as late as May 6. Influenza A and B viruses are the two main types of flu viruses that
routinely spread in humans and are responsible for seasonal flu epidemics each year 7.
Throughout a flu season, different types and subtypes of influenza viruses circulate and cause
illness. The variety of flu viruses spreading can affect people differently based on differences in
their immune systems 8.
Clinical Presentation:
While it can be difficult to tell the difference between flu and the common cold, flu
illness is generally worse with more intense symptoms 9. Symptoms of flu can include fever,
cough, sore throat, runny or stuffy nose, body aches, headaches, chills and fatigue. Some people
may experience vomiting and diarrhea 10. It’s possible that some people infected with flu will
show no symptoms (asymptomatic) or have only respiratory symptoms without a fever. Because
signs and symptoms may vary between mild and severe, clinical presentation alone may not
provide a precise measure of flu severity 11.
Most people who develop flu illness will recover in several days to less than two weeks10.
Some people will develop complications (such as pneumonia) that can result in hospitalization or
death, but most often this occurs in high risk populations (young children, older adults, pregnant
women, and people with underlying medical conditions) 11. Other possible serious complications
of flu can include myocarditis, encephalitis, myositis, and multi-organ failure. Flu can also make
chronic medical problems worse11.
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While some studies analyzing flu severity have found contradictory results among
symptoms, complications and underlying conditions, others suggest differences in severity
among the different flu viruses that cause flu illness11. For example, some evidence suggests that
influenza A(H1N1)pdm09 virus results in more severe complications among people (such as
ICU admission and pneumonia) compared to other flu virus subtypes 11.
Risk Factors:
While flu can make anyone ill, certain people are at greater risk of developing serious flurelated complications. High risk groups include adults 65 years and older, people with certain
chronic medical conditions, pregnant women, children younger than 5 years of age, and
especially those younger than 2 years of age. Both health and age play a factor in increasing a
person’s risk of serious complications from flu. For example, older adults and young children,
have increased exposure to influenza in communal settings, like nursing homes and schools 12.
Certain chronic medical conditions such as asthma, chronic lung disease, heart disease,
diabetes, and weakened immune systems can increase a person’s risk for hospitalization and
other severe outcomes 12–14. About half of children hospitalized for flu have at least one preexisting high risk medical condition 15,16. Despite seasonal variation, certain groups of children
are consistently at higher risk for flu-associated hospitalization 15.
There are important age-related differences in the epidemiology, clinical presentation,
and outcomes of people hospitalized with flu, by virus type and subtype 11,12,16. Chaves et al.
found that children hospitalized with A(H1N1)pdm09 or influenza B more frequently had a
longer hospital stay (more than 5 days) compared to those hospitalized with influenza A(H3N2).
Additionally, ICU admissions and pneumonia diagnoses occurred more frequently among
children hospitalized with A(H1N1)pdm09. Risk factors for hospitalization may differ during a
season when a novel virus emerges and needs to be evaluated rapidly to inform interventions 14.
Most studies fail to control for potential confounding factors, such as age and underlying
medical conditions 11. Evaluating age- and health-related differences in flu-associated
hospitalization rates can better inform surveillance, prevention and treatment efforts among
specific age groups 12.
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Influenza Virus Types:
There are four types of influenza viruses: A, B, C and D 17. Influenza A and B are the
virus types that circulate each flu season in the United States. Two influenza A subtypes and two
influenza B lineages cocirculate at different proportions during annual flu epidemics 8. Influenza
A viruses are the only flu viruses known to cause flu pandemics, which can occur when a new or
different influenza A virus emerges that can both infect people and can easily spread between
people 17. Influenza A viruses are divided into subtypes based on two proteins on the surface of
the virus, known as hemagglutinin (H) and neuraminidase (N). Subtypes of influenza A viruses
that routinely circulate in people include A(H1N1)pdm09 and A(H3N2) 17. While influenza A
viruses are classified into subtypes, influenza B viruses are classified into two lineages:
B/Yamagata and B/Victoria 17.
Flu has been described as “an unvarying disease caused by a varying virus” 11. Through
‘antigenic drift’, flu virus genes can mutate, leading to changes to their surface proteins. Antigen
drift happens continually over time as the virus replicates 18. Through ‘antigenic shift’, major
changes in the flu virus can occur, resulting in a new virus subtype in humans. When shifts
occur, most people have little or no immunity against the new virus. Shifts in influenza viruses
occur less frequently than drifts 18. Influenza A viruses have evolved and emerged or re-emerged
during the past century 8. In 1977, H1 viruses re-emerged and began to cocirculate with H3
viruses 8. As flu viruses continue to evolve, it will be necessary to revisit previous analyses to
determine whether morbidity and mortality patterns remain or change 8.
The notion that flu illness caused by different virus types and subtypes is clinically
indistinguishable, suggesting that different flu types and subtypes have no difference on the
severity of flu illness, has been challenged 11. Studies have estimated that clinical presentation,
severity, and risk of severe flu-related complications may differ across virus types and subtypes
11

. It’s important to understand the association of virus type and subtype on flu severity due to its

implications for the clinical management of flu patients and preparedness for seasonal epidemics
11

. Most studies conclude influenza A virus to be the predominant virus type to circulate during

most seasons compared to influenza B virus 8,12,15. Caini et al. claims that it’s important to study
influenza virus subtypes separately to find differences in the outcomes and severity.
Influenza A viruses were further studied by subtype and found A(H3N2) predominated
during most seasons compared to A(H1N1) 12. Numerous studies have found flu-associated
hospitalizations and deaths are highest in H3N2-predominant seasons, suggesting symptoms and
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severity of flu may be worse for this subtype 11,16. Chaves et al. found that studies conducted
prior to the 2009 H1N1 pandemic comparing disease severity in children by virus type and
subtype have often suggested that influenza B viruses cause milder flu illness compared to
influenza A viruses. Despite common assumptions that A(H3N2) infections result in more severe
flu illness and that influenza B infections are milder, a literature review studying the
characteristics of different flu virus types and subtypes didn’t reveal such differences 11. Some
studies found influenza A(H1N1)pdm09 to be associated with more severe flu illness compared
to other influenza strains 8,11. Another analysis found that influenza B was associated with
influenza complications similar to those associated with influenza A(H3N2) viruses, while some
studies suggest influenza A(H1N1)pdm09 was not as clinically severe compared to seasonal
influenza A and B viruses in previous seasons 16. Chaves et al. found that of the children with
severe influenza, most were associated with influenza B virus (48.9%), followed by
A(H1N1)pdm09 (26.9%) and A(H3N2) virus (24.1%).
Budd (2019) studied differences in risk of flu-associated disease by influenza virus
subtypes among birth cohorts, comparing pre-pandemic and pandemic and later periods. They
found that since the 2009 H1N1 influenza pandemic, there has been a paradigm shift finding
more severe flu disease and burden during H1NI predominant seasons rather than H3
predominant seasons 8. This more recent literature conflicts with previous findings. Studies
analyzing influenza A(H1N1)pdm09 suggest that knowing the causal virus may be an important
element for healthcare providers, especially with the virus subtype being associated with a higher
risk of unfavorable outcomes 11. Comparing the A(H1N1)pdm09-associated clinical severity
with that caused by H3N2 and B viruses is helpful to understand the predictors of severity among
hospitalized persons 16. Additional well-designed studies are needed to strengthen the evidence
showing differences in death and hospitalization rates among different virus subtypes 11.
Studying the implications of flu virus types and subtypes can produce more accurate cost-benefit
estimates of flu vaccination campaigns and other prevention and control strategies 11.
Disease Burden:
While the numbers can vary, in the United States, millions of people get sick, hundreds of
thousands are hospitalized, and thousands of people die from flu every year 19. The burden of
influenza can differ substantially from season to season depending on the characteristics of
circulating viruses, the timing of the season, population immunity to circulating viruses, flu
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vaccine effectiveness, and how many people received a seasonal flu vaccine 20. While the impact
of flu varies widely, it places a substantial burden on the health of people in the U.S. each
year14,20.
Flu viruses change constantly and as a result can cause significant morbidity and
mortality during seasonal epidemics and periodic pandemics 8. Since 1976, the highest rates of
severe flu-related illness and death usually occur in seasons where H3 viruses are most
commonly circulating 8. Influenza A hospitalization rate and death rate was higher during prepandemic H3 predominant seasons compared to H1 predominant season for all ages 8,12. While
older adults continue to have a higher mean hospitalization rate during seasons when H3N2
viruses are predominant over H1 predominant viruses, younger adults had higher mean
hospitalization rates during H1 predominant seasons 8.
Immunologic imprinting suggests that the flu virus that an individual is first infected with
has a lasting impact on their immunology and on subsequent immune responses. Antigen
imprinting or antigenic seniority suggests relative immune responses to each subsequent strain
one is infected with and the antibody response is highest against viruses a person is exposed to in
childhood 8. Analyzing influenza by birth cohort rather than traditional age groups suggests that
initial influenza A virus subtype exposure may affect the clinical impact of influenza in
subsequent years 8. This type of analysis can help with the understanding of the complex factors
at play affecting the clinical impact of flu virus infection.
Patients admitted to an ICU and patients who died during hospitalization are typically
classified as having had severe influenza illness 16. Dawood et al. found the median length of
hospitalization to be 3-4 days. A study found that the highest rates of hospitalizations occurred
among children less than 6 months of age. This could be because a flu vaccine is not approved
for children less than 6 months of age 15. Forty percent of hospitalized children had at least 1
underlying medical condition, putting them at higher risk for severe influenza. Of the 75% of
children who received a chest radiograph, 32-38% showed evidence of pneumonia. Additionally,
11-14% of hospitalized children required intensive care unit admission and 3-7% required
mechanical ventilation 15. Rates of influenza-associated hospitalization in children varied as
much as 3-fold from season to season. This calls for multi-season surveillance 15.
Caini et al. found overall hospitalizations and flu-associated deaths were highest in
A(H3N2)-predominant seasons, followed by influenza B- or influenza A(H1N1)-predominant
seasons. These study findings were not based on individual-level clinical data but instead
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modeled data 11. It’s important to note that the number of flu illnesses, hospitalizations and
deaths is thought to be higher than what is reported by states because not all cases are detected
and reported. CDC estimates the influenza burden using a combination of multiple sources of
estimates to account for likely under-reporting 20. Annual flu burden estimates show the
substantial health impact of flu and stresses the need to ensure vaccination of everyone 6 months
and older. Understanding clinical characteristics and severity of different flu types and subtypes
may help in detecting changes early to possibly indicate the emergence of a novel virus strain.
Detecting novel influenza viruses early is imperative to prevent the spread of a new virus that
could turn into a pandemic. Early detection of novel viruses is important for communication
purposes to better prepare for the impact of seasonal epidemics 11. Additionally, having better
characterization of patients hospitalized for flu can improve flu burden estimates based on
hospitalization surveillance 14.
Influenza Surveillance
The U.S. influenza surveillance system is a collaborative effort between CDC, state, local
and territorial health departments, public health and clinical laboratories, vital statistics offices,
clinicians, clinics and emergency departments 21. Information from data sources is collected to
report and predict current influenza activity, determine what flu viruses are circulating, detect
changes in flu viruses, and measure the impact of flu illness, hospitalizations and deaths.
Maintaining an influenza surveillance system is important because flu viruses are constantly
changing, therefore ongoing data collection and virus characterization is needed. Since the 2009
H1N1 influenza pandemic, the overall mean number of specimens tested per flu season
increased, increasing flu laboratory testing 8. With flu viruses shifting and drifting, surveillance
can detect these changes and inform public health response. Flu surveillance and research is also
used to monitor the impact flu has on different fragments of the population 21.
The following U.S. surveillance systems capture clinically significant influenzaassociated illness: The World Health Organization (WHO) Collaborating Laboratories System,
the U.S. Influenza Hospitalization Surveillance Network (FluSurv-NET), and the National
Center for Health Statistics (NCHS) Mortality Surveillance System 8. Hundreds of public health
and clinical labs located throughout the U.S. participate in flu surveillance through the WHO
Collaborating Lab System. Laboratory data provides useful information on timing and intensity
of flu activity as well as characterization data for what virus types are circulating and the age
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groups being affected 21. FluSurv-NET conducts population-based surveillance for laboratoryconfirmed flu-associated hospitalizations among children and adults through a network of acute
care hospitals. Data are used to estimate the annual influenza disease burden and burden averted
by influenza vaccination, as well as estimating the seasonal influenza severity. Additionally, this
data informs the use and effects of influenza vaccines and antivirals 21. NCHS collects death
certificate data from state vital statistics offices for all deaths in the U.S. This data is used to
calculate the percentage of deaths that occur in a given week that had pneumonia and/or flu listed
as the cause of death 21.
Flu hospitalization surveillance is collected through FluSurv-NET. This system identifies
cases from laboratory reports and actively reviews hospital records to compare demographic and
clinical characteristics of cases by type and subtype of flu viruses 16. Detailed demographic and
medical history were collected, including age, sex, medical comorbidities, flu vaccination status,
and antiviral medications. This detailed patient data allows us to evaluate important demographic
and clinical features, epidemiologic exposures and specific clinical outcomes. It’s important to
note that lab testing is ordered at the discretion of a clinician providing care. This could lead to
bias towards more severe cases and under-estimation of burden due to un-tested potential cases
15,16

. Monitoring the incidence and clinical characteristics of flu-related hospitalizations over

multiple seasons and surveillance sites is important to understand the flu disease burden in all
ages, measuring the impact of current prevention programs, and guiding future prevention and
treatment strategies 12,15.
Prevention and Treatment:
The best way to prevent seasonal influenza illness and its potentially serious
complications is to get an annual flu vaccine. While there are many different flu viruses, flu
vaccines prevent against the three or four viruses research suggests will be most commonly
circulated that season 22. Three-component (trivalent) flu vaccines contain an H3N2, H1N1 and
B virus. Four-component (quadrivalent) flu vaccines have an additional B virus component. Flu
vaccination can reduce flu illness, doctors’ visits and missed work and school because of flu, as
well as prevent flu-related hospitalizations. Because of their increased risk, children and older
adults are considered some of the priority groups for flu vaccination, among others 12.
It is recommended that everyone 6 months and older get a flu vaccine each year because
flu viruses are constantly changing. Flu vaccines may need to be updated from one season to the
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next to protect against the viruses that research suggests may be most common during the
upcoming flu season. Recent studies show flu vaccine can reduce the risk of overall flu illness by
approximately 40-60%, depending on how well the vaccine matches what flu viruses are
circulating throughout the season 23. Since influenza vaccines were developed, H1 viruses
exhibited fewer substantial antigenic changes, needing fewer vaccine strain updates than H3
viruses8. Additionally, annual flu vaccination is recommended because a person’s immune
protection from the vaccine declines over time. Some children aged 6 months through 8 years
will require two doses of flu vaccine spaced at least 4 weeks apart for best protection from flu 15.
Typically this includes children in this age group getting vaccinated for the first time and those
who have only previously gotten one dose of vaccine 24. For children and adults who need only
one dose, getting vaccinated early (i.e. July or August) may be associated with reduced
protection against flu infection later in the flu season, especially among older adults.
While CDC recommends everyone 6 months and older get a flu vaccine by the end of
October each season, as long as flu viruses are circulating, people can receive a flu vaccine later
in the season, even in January or later. It’s best to get vaccinated before flu viruses begin
spreading in a community so a person’s body develops the antibodies needed to provide the best
protection against flu illness.
Most people with flu experience mild illnesses and do not need medical care or antiviral
drugs 25. For people who get sick with flu and are in high risk groups (i.e. young children and
older adults) or are very sick, should receive prompt medical care. There are antiviral drugs that
can be used to treat flu illness. Antiviral drugs are prescription medications that can make illness
milder and shorten the time you are sick. They can also prevent serious flu complications, like
pneumonia. Antiviral drugs work best when taken soon after illness onset to treat people who are
very sick or hospitalized for flu and people who have a greater chance of developing serious flu
complications because of their age or having an underlying medical condition 25. While there are
studies that show early antiviral medication works best for treating influenza, one study found
that fewer than half of children with positive influenza received antiviral treatment during their
hospital stay 15. This stresses the importance for antiviral treatment guidance targeting high risk
populations in outpatient settings 14.
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Manuscript
Introduction
Influenza (flu) is a contagious respiratory illness caused by influenza viruses that can
cause mild to severe illness. Serious outcomes of flu infection can result in hospitalization or
death 1. Young children, especially children younger than two years, are at high risk of
developing serious flu-related complications requiring hospitalization. Complications of flu
among children can include pneumonia, dehydration, worsening of long-term medical problems
(i.e. heart disease or asthma), brain dysfunction, and sinus problems and ear infections 2.
Each year, millions of children get sick with seasonal flu, thousands of children are
hospitalized, and some children die from flu. CDC estimates that since 2010, flu-related
hospitalizations among children younger than 5 years ranges from 7,000 to 26,000 in the United
States 2. Since the 2004-2005 influenza season when flu-related pediatric deaths became a
nationally notifiable condition, flu-related deaths in children reported to CDC during regular flu
seasons ranged from 37 deaths (during the 2011-2012 season) to 188 deaths (during the 20172018 season) 2.
Flu vaccination can prevent illness, hospitalization and death in children. A study
published in 2017 was one of the first to show that flu vaccination can significantly reduce a
child’s risk of dying from the flu, highlighting the importance of children receiving a seasonal flu
vaccine each year 3. While the percentage of children receiving their annual flu vaccination in the
U.S. has been increasing over the years (~63% among children 6 months- 17 years during the
2018-2019 flu season), flu continues to cause a heavy burden among this vulnerable population 4.
This is partially due to the variability in how well the flu vaccine works to protect against flu
illness from year to year.
Flu vaccines are made to protect against either three or four different influenza viruses
research shows are most likely to spread and cause illness among people during the upcoming flu
season. Since flu viruses are constantly changing, flu vaccines may be updated from one season
to the next based on which flu viruses are making people sick, how the viruses are spreading, and
how well the previous season’s flu vaccines protected against the circulating flu viruses.
The purpose of this study was to identify the trends of seasonal flu viruses that most
commonly circulate among children in the United States hospitalized for influenza since the
2010-2011 influenza season. Understanding these trends is useful for guiding prevention and
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control efforts surrounding flu-burdened children. This study is aiming to determine whether
certain flu viruses increase the burden of flu among children ages 0-4 years and to determine the
relationship between the proportion of flu among children and the proportion flu hospitalizations
among children across seasons. Based on previous literature, it’s predicted that influenza A
viruses have an increased burden among children compared to other flu virus types.
National and regional data was assessed from the U.S. influenza surveillance systems.
Lab-confirmed hospitalization data was analyzed to identify trends in hospitalization rates
among children over nine consecutive flu seasons. Circulating virus subtypes and lineages from
U.S. virologic surveillance were analyzed and compared with hospitalization rates among
children to analyze patterns in seasonal flu viruses among children hospitalized for flu.
Understanding these trends will help to better conceptualize the burden of flu among children.
Methods
Study
This study was a cross-sectional, secondary analysis of existing U.S. national influenza
surveillance data provided by the CDC (2010-2019). The study population for this analysis
included children with laboratory-confirmed influenza monitored through public health
laboratory virologic surveillance and children with influenza-associated hospitalization residing
in the United States, monitored through the Influenza Hospitalization Surveillance Network
(FluSurv-NET).
Variables
For each flu season, positive flu specimens and weekly hospitalization rates were
analyzed. CDC’s influenza seasons are tracked from Week 40 through Week 39 of the following
year. Young children were further analyzed against all other ages by creating proportion
variables (children 0-4 yrs/all other ages) in each data set.
Hospitalization cases for influenza are confirmed by a laboratory test. It’s important to
note that testing is clinician-directed, meaning that someone with influenza will only be
confirmed and captured by surveillance if a clinician orders an influenza test and the test is
positive.
For each season, public health laboratory data on the circulating virus subtype (Influenza
A) and lineage (Influenza B) are presented by age group (0-4 years, 5-24 years, 25-64 years and
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65+ years) 26. Influenza virus subtypes A(H1N1)pdm09 and A(H3N2) were tracked along with
virus lineages B/Victoria and B/Yamagata. This data was obtained from the virologic
surveillance system. Two virus subtypes from the virologic data, flu H3N2v (variant flu) and
H1N1 (pre 2009 virus), were excluded from this analysis.
Data Source
The Influenza Division at CDC collects and analyzes the information provided by the
collaborative surveillance system conducted by the CDC and its partners in state, local, and
territorial health departments, public health and clinical laboratories, vital statistics offices,
healthcare providers, clinic and emergency departments. A weekly influenza surveillance report,
FluView, is prepared by CDC’s Influenza Division with data they compile from the U.S.
influenza surveillance system. Additionally, FluView Interactive is an online application
managed by the Influenza Division that allows for more in-depth exploration of flu surveillance
data. The comprehensive system contains five categories of flu surveillance21. Data from
hospitalization surveillance and virologic surveillance were used for this analysis.
The U.S. Influenza Hospitalization Surveillance Network (FluSurv-NET) is a populationbased surveillance network covering more than 27 million people, representing 9 percent of the
U.S. population. The network consists of more than 70 counties in 13 states that participate in the
10 Emerging Infections Program (EIP) states (CA, CO, CT, GA, MD, MN, NM, NY, OR, and
TN) and the Influenza Hospitalization Surveillance Program (IHSP) (Figure 1)27(p). The IHSP
started during the 2009-2010 season in effort to enhance influenza surveillance following the
2009 H1N1 flu pandemic. IHSP sites have fluctuated over the years, but since the 2013-2014
influenza season include MI, OH and UT 21. Detailed demographic and medical history are
collected and displayed in this surveillance system, including age, sex, medical comorbidities, flu
vaccination status, and antiviral medications. This detailed patient data allows us to evaluate
important demographic and clinical features, epidemiologic exposures and specific clinical
outcomes.
U.S. virologic surveillance data is sourced from approximately 100 public health
laboratories and more than 300 clinical laboratories throughout all 50 states, Puerto Rico, Guam
and the District of Columbia (DC). The labs perform subtyping tests on respiratory samples from
patients exhibiting influenza like illness (ILI) and report data regarding flu virus type and
subtypes through either the U.S. WHO Collaborating Laboratories System or the National
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Respiratory and Enteric Virus Surveillance System (NREVSS). Flu testing practices differ in
public health and clinical laboratories. While clinical labs primarily test for diagnostic purposes,
providing useful information on timing and intensity of flu activity, public health labs help us
understand what flu virus types, subtypes, and lineages are circulating and the age groups being
affected. Since the distribution and proportion of positive flu specimens by age and virus subtype
and lineage are reported from public health laboratories, public health laboratory virologic
surveillance data from this system were utilized for this analysis 21.
Statistical Methods
Secondary data was downloaded from CDC’s FluView Interactive application. Microsoft
Excel was used to organize and clean the data. SAS 9.4 was used for re-coding variables and
performing statistical analyses. An alpha level of 0.05 was used for all statistical tests.
Linear regression models were analyzed (proc reg in SAS) to observe possible trends
among variables: the proportion of flu among children over time, the proportion flu-related
hospitalizations among children over time, and the proportion of flu virus types among children
over time.
The following correlations were tested (proc corr in SAS) across flu seasons: proportion
of flu among children (0-4 yr) and proportions of flu among other age groups (5-24 yr, 25-64 yr,
65+ yr), proportion of flu-related hospitalizations among children (0-4 yr) and proportion of flurelated hospitalizations among other age groups (5-17 yr, 18-49 yr, 50-64 yr, 65+ yr), and
proportion of flu among children (0-4 yr) and proportion of flu-related hospitalizations among
children (0-4 yr).
Results
Trends reveal that the proportion of flu among children (0-4 yr) has been decreasing over
time (2010-2019) (-0.008; CI: [-0.014, -0.001]; p=0.0383; Table 1; Figure 2). Similarly, trends
show the proportion of flu-related hospitalizations among children (0-4 yr) has been decreasing
over time (2010-2019) (-0.020; CI: [-0.034, -0.006]; p=0.0129; Figure 3; Table 3). While this
downward trend was also revealed in the proportion of flu A(H3N2) virus among children (0-4
yr) over time (2010-2019) (-0.010; CI: [-0.018, -0.003]; p=0.0129; Figure 4), no other virus type
revealed a significant trend (Figure 5, Figure 6, Table 2).
The proportion of flu among children (0-4 yr) and the proportion of flu among older
children (5-24 yr) have a fairly strong, positive relationship (r = 0.8307, p=0.0055). However,
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the analysis shows a fairly strong, negative relationship between the proportion of flu among
children (0-4 yr) and the proportion of flu among older adults (65+ yr) (r = -0.762, p=0.0170).
Similar to the virologic data, the proportion of flu-related hospitalizations among children
(0-4 yr) and the proportion of flu hospitalizations among older children (5-17 yr) have a fairly
strong, positive relationship (r = 0.886, p=0.0015). Likewise, the proportion of flu
hospitalizations among young children (0-4) has a moderately, positive relationship with the
proportion of flu hospitalizations among adults (18-49 yr) (r=0.68350, p=0.0424). However, the
analysis shows a fairly strong, negative relationship between the proportion of flu
hospitalizations among children (0-4 yr) and proportion of flu hospitalizations among older
adults (65+ yr) (r = -0.853, p=0.0035) (Figure 7).
Lastly, there appears to be a very strong, positive relationship between the proportion of
flu among children (0-4 yr) and the proportion of flu hospitalizations among children (0-4 yr)
(correlation= 0.9183, p=0.005).
Discussion
Since the 2010-2011 flu season, data has revealed a downward trend in the proportion of
flu among young children (0-4 yr). This decrease was similarly revealed in the proportion of flu
hospitalizations among children. The Pearson correlation coefficient revealed that the proportion
of flu among children had a strong, positive relationship with the proportion of flu-related
hospitalizations among children (Table 4). This reinforces our findings that over time, as the
proportion of flu among children decreased, the proportion of flu-hospitalizations among
children similarly decreased. The analysis also indicated a strong, negative relationship between
the proportion of flu among children and the proportion of flu among older adults over time. This
finding reveals that as the proportion of flu and flu hospitalizations among children decreased,
the proportion of flu and flu hospitalizations among older adults increased over time. This
finding is significant as it uncovers that children have experienced less of a burden from flu
compared to older age groups in the past decade.
This study also found that the proportion of flu A(H3N2) virus among children (0-4 yr)
decreased over time; however, there is insufficient evidence to conclude trends among other
virus types in this age group over time. Though numerous studies have found overall flu burden
to be highest among H3N2-predominant seasons, this analysis reinforces current literature
proposing there are contradictory results suggesting no differences among flu virus types and
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subtypes on overall flu burden. Additional well-designed studies are needed to strengthen the
evidence showing differences in flu burden among different virus subtypes.
Limitations
Surveillance systems that rely on case reports only reveal information about positive tests;
therefore, we have limited knowledge regarding the people who test negative or never got a flu
test. The use of influenza data as an indicator for rates of flu activity may not reveal the true
burden of flu over time. Available data could be an underestimation of total flu cases, as the data
only includes people who sought healthcare for their symptoms.
Not all positive flu samples were subtyped in the virologic data. Influenza B virus lineage
was not specified until the 2015-2016 influenza season. Additionally, the flu hospitalization data
isn’t presented by virus subtype among age groups; therefore, studying the trends in virus
subtypes and lineages by age among flu hospitalizations if limited. Future research assessing flu
hospitalization data by virus subtypes and lineages and age may help identify common factors
leading to flu burden among specific age groups. Additionally, future research analyzing the risk
factors for hospitalizations among different age groups during a flu season when a novel virus
emerges would be beneficial.
Conclusion
While the U.S. has a comprehensive influenza surveillance system reporting on current flu
activity, and the Centers for Disease Control and Prevention (CDC) publishes weekly updates on
their website (FluView), there is a lack of literature analyzing trends among the virus types
causing flu and flu-related hospitalizations among children over multiple flu seasons. In this
study, a decrease in proportion of flu and proportion of flu-related hospitalizations among
children was observed over time (2010-2019). From the analysis on virus types, a decrease in the
proportion of influenza A(H3N2) among children was observed over time. While the proportion
of flu among young children had a positive relationship with the proportion of flu among older
children, the proportion of flu among children had a negative relationship with the proportion of
flu among older adults. Similar relationships were seen among the hospitalization data (Figure
6). Trends in seasonal flu and flu-related complications have important implications for flu
prevention and control efforts. Understanding these trends over time can result in targeting more
vulnerable audiences with strong flu vaccine recommendations and control strategies.
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Table 1. Virologic Flu Surveillance: Total Flu Serotypes | Proportion Among Children
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Table 2. Virologic Flu Surveillance: Flu Serotypes by Virus Type| Proportion Among Children
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Table 3. Flu Hospitalization Surveillance: Flu Hospitalization Rate| Proportion Among Children
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Table 4. Pearson Correlation Coefficients Among Variables
Variable

Proportion of Flu Among

Proportion of Flu-Related

Children (0-4 yr)

Hospitalizations Among
Children (0-4 yr)

Proportion of Flu Among
Children (0-4 yr)
Proportion of Flu Among
Older Children (5-24 yr)
Proportion of Flu Among
Adults (25-64 yr)
Proportion of Flu Among
Older Adults (65+ yr)

Proportion of Flu-Related

Correlation: 0.918
p-Value:0.001
N=9
Correlation: 0.831
p-Value: 0.006
N=9
Correlation: 0.002
p-Value: 0.997
N=9
Correlation: -0.762
p-Value:0.017
N=9

1.000

1.000

Correlation: 0.918
p-Value:0.001
N=9

Correlation: 0.951
p-Value:<.0001
N=9

Correlation: 0.886
p-Value:0.002
N=9

Correlation: 0.434
p-Value:0.2431
N=9

Correlation: 0.684
p-Value:0.042
N=9

Correlation: -0.165
p-Value:0.671
N=9

Correlation: 0.071
p-Value:0.857
N=9

Correlation: -0.668
p-Value:0.050
N=9

Correlation: -0.853
p-Value:0.004
N=9

Hospitalizations Among
Children (0-4 yr)
Proportion of Flu-Related
Hospitalizations Among
Older Children (5-17 yr)
Proportion of Flu-Related
Hospitalizations Among
Adults (18-49 yr)
Proportion of Flu-Related
Hospitalizations Among
Adults (50-64 yr)
Proportion of Flu-Related
Hospitalizations Among
Older Adults (65+ yr)

Correlation: 0.685
p-Value:0.042
N=9
Correlation: 0.284
p-Value:0.459
N=9
Correlation: -0.883
p-Value:0.002
N=9
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Figure 1. Percentage of State Population Represented by Participating FluSurv-NET Counties [26]
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Figure 2. Proportion of flu among children (0-4 yr) per flu season
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Figure 3. Proportion of flu hospitalizations among children (0-4 yr) per flu season
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Figure 4. Proportion of flu A(H3N2) among children (0-4 yr) per flu season
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Figure 5. Proportion of flu virus among children (0-4) over time by virus type (total)
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Figure 6. Proportion of flu virus types among children (0-4 yr) over time by virus type
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Figure 7. Total flu virus serotypes by age group over time (2010-2019)
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